【瑞康医药：控股股东终止协议转让公司部分股份】瑞康医药晚间公告，因客观环境发生重大变化，公司控股股东张仁华与岩泉8号基金同意终止2024年8月签署的《股份转让协议》。该协议约定，张仁华将其持有的公司股份7600万股转让给岩泉8号基金，转让价格2.13元/股，总价款1.62亿元。

金融界2025-06-02

瑞康医药晚间公告，因客观环境发生重大变化，公司控股股东张仁华与岩泉8号基金同意终止2024年8月签署的《股份转让协议》。该协议约定，张仁华将其持有的公司股份7600万股转让给岩泉8号基金，转让价格2.13元/股，总价款1.62亿元。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2540676555?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-06-02 16:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2540676555","market":"us","top_or_hot":-1,"title":"【瑞康医药：控股股东终止协议转让公司部分股份】 瑞康医药晚间公告，因客观环境发生重大变化，公司控股股东张仁华与岩泉8号基金同意终止2024年8月签署的《股份转让协议》。该协议约定，张仁华将其持有的公司股份7600万股转让给岩泉8号基金，转让价格2.13元/股，总价款1.62亿元。","media":"金融界","content":"<div>\n<p>瑞康医药晚间公告，因客观环境发生重大变化，公司控股股东张仁华与岩泉8号基金同意终止2024年8月签署的《股份转让协议》。该协议约定，张仁华将其持有的公司股份7600万股转让给岩泉8号基金，转让价格2.13元/股，总价款1.62亿元。</p>\n\n<a href=\"https://24h.jrj.com.cn/2025/06/02160450809333.shtml\">网页链接</a>\n\n</div>\n","source":"jinrongjie_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>【瑞康医药：控股股东终止协议转让公司部分股份】 瑞康医药晚间公告，因客观环境发生重大变化，公司控股股东张仁华与岩泉8号基金同意终止2024年8月签署的《股份转让协议》。该协议约定，张仁华将其持有的公司股份7600万股转让给岩泉8号基金，转让价格2.13元/股，总价款1.62亿元。</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n【瑞康医药：控股股东终止协议转让公司部分股份】 瑞康医药晚间公告，因客观环境发生重大变化，公司控股股东张仁华与岩泉8号基金同意终止2024年8月签署的《股份转让协议》。该协议约定，张仁华将其持有的公司股份7600万股转让给岩泉8号基金，转让价格2.13元/股，总价款1.62亿元。\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-06-02 16:04 北京时间&nbsp;&nbsp;&nbsp;<a href=https://24h.jrj.com.cn/2025/06/02160450809333.shtml><strong>金融界</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>瑞康医药晚间公告，因客观环境发生重大变化，公司控股股东张仁华与岩泉8号基金同意终止2024年8月签署的《股份转让协议》。该协议约定，张仁华将其持有的公司股份7600万股转让给岩泉8号基金，转让价格2.13元/股，总价款1.62亿元。</p>\n\n<a href=\"https://24h.jrj.com.cn/2025/06/02160450809333.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0197","symbol_name":"中小创蓝筹","start_time":0,"source_url":"https://24h.jrj.com.cn/2025/06/02160450809333.shtml","article_id":"2540676555","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2540676555","pubTimestamp":1748851472,"columns":[],"sourceInfo":{"source_id":"jinrongjie_stock","name":"金融界"},"weMediaInfo":null,"summary":"瑞康医药晚间公告，因客观环境发生重大变化，公司控股股东张仁华与岩泉8号基金同意终止2024年8月签署的《股份转让协议》。该协议约定，张仁华将其持有的公司股份7600万股转让给岩泉8号基金，转让价格2.13元/股，总价款1.62亿元。","collect":0,"end_time":0,"defaultTopTitle":"jrj.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK0197":"中小创蓝筹","BK0185":"二线龙头","BK0132":"高送转概念","BK0070":"员工持股","002589":"瑞康医药","BK0077":"质押式回购","BK0250":"批发"},"translate_title":"[Ruikang Pharmaceutical: The controlling shareholder terminates the agreement to transfer part of the company's shares] Ruikang Pharmaceutical announced in the evening that due to major changes in the objective environment, the company's controlling shareholder Zhang Renhua and Yanquan No. 8 Fund agreed to terminate the \"Share Transfer Agreement\" signed in August 2024. According to the agreement, Zhang Renhua will transfer 76 million shares of the company he holds to Yanquan No.8 Fund at a transfer price of 2.13 yuan/share and a total price of 162 million yuan.","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"002589":1},"content_text":"瑞康医药晚间公告，因客观环境发生重大变化，公司控股股东张仁华与岩泉8号基金同意终止2024年8月签署的《股份转让协议》。该协议约定，张仁华将其持有的公司股份7600万股转让给岩泉8号基金，转让价格2.13元/股，总价款1.62亿元。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2540676555","isCrawlerRequest":true}